There was "privileged and confidential" communication sent to the class action group members on 23 Jan.if you are a member you should have received it?if you are not, well then I don't understand the interest.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%